Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris

NCT02815332 is registered in ClinicalTrials.gov with BioPharmX, Inc. as lead sponsor.

NCT NCT02815332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02815332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Lead sponsor
BioPharmX, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2016
Completion date
March 24, 2017
Enrollment
225 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris